Voyxact (sibeprenlimab-szsl) — Prior authorization / medical necessity for primary IgA nephropathy
Customize your policy alerts
Sign up for all Colorado Rocky Mountain Health Plans policy alerts
Know when Colorado Rocky Mountain Health Plans releases new policies or updates existing guidance.
Monitor payer policy activity
Prior authorization and medical necessity criteria for Voyxact to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid progression; applies to Colorado Rocky Mountain Health Plans pharmacy benefit decisions.
Voyxact (sibeprenlimab-szsl) is included with prior authorization/medical necessity criteria.
SGLT2 step was removed from the program requirements.
Updated language in the steroid trial requirement.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.